Jeena Sikho Lifecare Ltd

Jeena Sikho Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Jeena Sikho Lifecare Ltd

₹ 2,136 6.66%
20 May - close price
Company website NSE - SME: JSLL
About

Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.

Key Points

Business Segment
a) Hospitals & Clinics Portfolio[1]
Jeena Sikho Lifecare Limited (JSLL) operates a network of 36 hospitals and 74 clinics/daycare centres across 21 states and 100+ cities in India. The hospitals have 1,530 operational beds, with another 518 beds in the pipeline.

Website NSE - SM
  • Market Cap ₹ 5,310 Cr.
  • Current Price ₹ 2,136
  • High / Low ₹ 2,499 / 998
  • Stock P/E 58.5
  • Book Value ₹ 110
  • Dividend Yield 0.20 %
  • ROCE 51.4 %
  • ROE 39.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 73.8% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 40.6%

Cons

  • Stock is trading at 19.4 times its book value
  • Promoter holding has decreased over last quarter: -2.31%
  • Debtor days have increased from 54.0 to 76.0 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
79 71 75 86 117 157 167 214 255
70 62 66 70 88 112 119 155 189
Operating Profit 9 9 9 16 30 45 48 59 66
OPM % 12% 13% 12% 19% 25% 29% 29% 28% 26%
0 1 0 1 1 1 5 6 0
Interest 1 1 1 1 0 0 0 0 0
Depreciation 1 1 2 1 2 2 3 3 6
Profit before tax 8 8 7 15 29 44 50 62 60
Tax % 29% 26% 26% 27% 23% 27% 26% 24% 27%
6 6 5 11 23 32 37 47 44
EPS in Rs 280.00 3.42 2.78 4.50 9.05 12.78 15.04 18.86 17.64
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
106 94 136 146 204 324 469
95 84 119 128 158 231 344
Operating Profit 11 11 17 18 46 93 125
OPM % 10% 11% 13% 12% 23% 29% 27%
0 1 1 1 2 6 6
Interest 1 2 1 1 1 0 1
Depreciation 1 2 2 3 3 5 9
Profit before tax 8 8 14 15 45 94 122
Tax % 28% 26% 27% 26% 24% 26% 26%
6 6 10 11 34 69 91
EPS in Rs 300.00 286.50 514.50 6.19 13.55 27.84 36.50
Dividend Payout % 0% 0% 0% 0% 8% 17% 15%
Compounded Sales Growth
10 Years: %
5 Years: 38%
3 Years: 47%
TTM: 45%
Compounded Profit Growth
10 Years: %
5 Years: 74%
3 Years: 104%
TTM: 34%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 191%
1 Year: 79%
Return on Equity
10 Years: %
5 Years: 41%
3 Years: 41%
Last Year: 39%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.10 0.10 0.10 10 14 25 25
Reserves 8 14 24 26 112 167 248
16 12 12 7 1 1 11
12 12 13 18 24 28 45
Total Liabilities 36 38 49 62 151 221 328
13 17 23 28 60 67 153
CWIP 0 0 0 5 1 4 13
Investments 0 0 0 0 5 4 3
23 21 26 28 86 146 159
Total Assets 36 38 49 62 151 221 328

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1 12 18 17 17 37 69
-11 -6 -8 -20 -57 -18 -70
7 -5 -2 -5 48 -3 -1
Net Cash Flow -2 1 8 -7 8 15 -2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 15 17 9 22 40 46 76
Inventory Days 204 315 208 136 87 121 135
Days Payable 125 168 73 109 129 75 111
Cash Conversion Cycle 94 163 143 49 -2 92 100
Working Capital Days 35 30 13 6 29 57 66
ROCE % 38% 50% 39% 53% 58% 51%

Shareholding Pattern

Numbers in percentages

Apr 2022Sep 2022Mar 2023Sep 2023Nov 2023Mar 2024Sep 2024Mar 2025
65.89% 65.89% 66.20% 67.91% 67.91% 67.91% 65.84% 63.53%
0.00% 0.00% 0.00% 2.00% 1.79% 0.26% 4.05% 5.95%
0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 0.07% 0.17%
34.11% 34.11% 33.80% 30.05% 30.30% 31.83% 30.04% 30.34%
No. of Shareholders 1,9518346638151,1072,7213,4235,967

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls